Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.91 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | HBB | P68871 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trichlormethine SCHEMBL338967 | 0.95 | LMNA (1.00) | LMNAMAPTTSHRTP53HTT | |
| Trichlormethine SCHEMBL1820371 | 0.95 | LMNA (0.83) | LMNAMAPTTSHRTP53HTT | |
| Trichlormethine SCHEMBL1651598 | 0.91 | LMNA (0.77) | LMNAMAPTTSHRTP53HTT | |
| SCHEMBL12552521 | 0.88 | LMNA (0.71) | LMNAMAPTTSHRTP53HTT | |
| SCHEMBL7039551 | 0.84 | LMNA (0.67) | LMNAMAPTTSHRTP53HTT | |
| SCHEMBL12552525 | 0.84 | LMNA (0.67) | LMNAMAPTTSHRTP53HTT | |
| SCHEMBL10540029 | 0.84 | LMNA (0.67) | LMNAMAPTTSHRTP53HTT | |
| SCHEMBL2615232 | 0.82 | LMNA (0.62) | LMNAMAPTTSHRTP53HTT | |
| SCHEMBL1252794 | 0.82 | LMNA (0.62) | LMNAMAPTTSHRTP53HTT | |
| SCHEMBL6048117 | 0.82 | LMNA (0.62) | LMNAMAPTTSHRTP53HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 18317 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743490-A1 | HUMANIZED ANTI-CD7 ANTIBODY | Christian-Albrechts-Universität zu Kiel (DE) | 2026-05-20 | — | — | EP | claimed |
| WO-2026099502-A1 | NOVEL DRUG CONJUGATES FOR TESTING CELLULAR DRUG UPTAKE | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2026-05-15 | — | — | WO | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-20260085100-A1 | METHODS OF ANTIGEN PRODUCTION | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2026-03-26 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| EP-4698185-A1 | METHODS AND SYSTEMS FOR IMPROVING ANTI-CANCER THERAPIES | Osasuna Therapeutics SA (CH) | 2026-02-25 | — | — | EP | claimed |
| EP-4694909-A1 | METHODS OF MODULATING THE EPITHELIAL-MESENCHYMAL TRANSITION | RS Oncology, LLC (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4687999-A1 | TROP2 CONJUGATED BIOLOGICAL MOLECULES, PHARMACEUTICAL COMPOSITIONS AND METHODS | OBI Pharma, Inc. (TW) | 2026-02-11 | — | — | EP | claimed |
| EP-4676544-A1 | ANTIBODY-DRUG CONJUGATE COMPRISING ANTIBODIES AGAINST HUMAN L1CAM AND USES THEREOF | LigaChem Biosciences Inc. (KR) | 2026-01-14 | — | — | EP | claimed |
| EP-3277381-B1 | NITROBENZYL DERIVATIVES OF ANTI-CANCER AGENTS | OBI PHARMA INC (TW) | 2026-01-07 | — | — | EP | claimed |
| WO-1999058126-B1 | USE OF NEOMYCIN FOR TREATING ANGIOGENESIS-RELATED DISEASES | ENDOWMENT RES INHUMAN BIOLOGY (US) | 2000-02-17 | — | — | WO | claimed |
| WO-1999058126-A1 | USE OF NEOMYCIN FOR TREATING ANGIOGENESIS-RELATED DISEASES | THE ENDOWMENT FOR RESEARCH IN HUMAN BIOLOGY, INC. (US) | 1999-11-18 | — | — | WO | claimed |
| JP-2907474-B2 | — | — | 1999-06-21 | — | — | JP | claimed |
| EP-0439540-B1 | ANTIBODY CONJUGATES WITH TWO OR MORE COVALENTLY LINKED FC REGIONS | 3I RES EXPL LTD (GB) | 1995-06-28 | — | — | EP | claimed |
| EP-0439540-A1 | ANTIBODY CONJUGATES WITH TWO OR MORE COVALENTLY LINKED FC REGIONS. | 3I RES EXPL LTD (GB) | 1991-08-07 | — | — | EP | claimed |
| WO-1990004413-A1 | ANTIBODY CONJUGATES WITH TWO OR MORE COVALENTLY LINKED Fc REGIONS | 3I RESEARCH EXPLOITATION LIMITED (GB) | 1990-05-03 | — | — | WO | claimed |
| US-4481373-A | CATALYTIC OXIDATION OF OLEFINS IN PRESENCE OF TERTIARY AMINE OF AMIDE | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1984-11-06 | — | — | US | claimed |
| EP-0005094-B1 | PROCESS FOR THE PREPARATION OF TRIS-(POLYOXAALKYL)-AMINES | RHONE-POULENC INDUSTRIES (FR) | 1980-10-29 | — | — | EP | claimed |
| EP-0005090-B1 | PROCESS FOR THE PREPARATION OF TRIS(8-HYDROXY-3,6-DIOXA-OCTYL)-AMINE, AND THE COMPOUND OBTAINED BY THIS PROCESS | RHONE-POULENC INDUSTRIES (FR) | 1980-10-01 | — | — | EP | claimed |
| US-4073633-A | Topical nitrogen fertilization method | UNION OIL COMPANY OF CALIFORNIA (US) | 1978-02-14 | — | — | US | claimed |